Coccia G, Bortolotti M, Michetti P, Dodero M
Department of Gastroenterology, Galliera Hospital, Genova, Italy.
Gut. 1991 Jun;32(6):604-6. doi: 10.1136/gut.32.6.604.
A study was carried out in 30 patients affected by a mild or moderate degree of oesophageal achalasia to compare the clinical and manometric effects of sublingual nifedipine and pneumatic dilatation. Sixteen patients were dilated twice with Rider-Moeller dilators and 14 were treated with sublingual nifedipine 10-20 mg 30 minutes before meals. A manometric evaluation was performed before and six months after starting treatment. The clinical evaluation (according to Vantrappen's criteria) was performed every three months for a mean follow up of 21 months. In both groups of patients a significant (p less than 0.001) fall in lower oesophageal sphincter pressure was observed after treatment and excellent or good clinical results were observed in 75% of dilated patients and in 77% of patients treated with nifedipine. One patient could not tolerate nifedipine. No complications were observed after dilatation. It is concluded that longterm treatment with sublingual nifedipine and pneumatic dilatation are equally effective in the treatment of oesophageal achalasia of mild or moderate degree.
对30例轻、中度食管贲门失弛缓症患者进行了一项研究,以比较舌下含服硝苯地平和气囊扩张术的临床及测压效果。16例患者使用里德 - 默勒扩张器进行了两次扩张,14例患者在饭前30分钟舌下含服10 - 20毫克硝苯地平。在开始治疗前及治疗6个月后进行了测压评估。每三个月进行一次临床评估(根据万特拉彭标准),平均随访21个月。两组患者治疗后食管下括约肌压力均显著下降(p < 0.001),75%的扩张患者和77%的硝苯地平治疗患者获得了良好或优秀的临床效果。1例患者不能耐受硝苯地平。扩张术后未观察到并发症。结论是,舌下含服硝苯地平和气囊扩张术长期治疗轻、中度食管贲门失弛缓症同样有效。